Trials / Completed
CompletedNCT01056692
OC000459 Bronchial Allergen Challenge
A Phase II Study of oc000459 in Subjects With Allergic Asthma; a Randomised, Double Blind, Two Way Balanced Crossover Comparing oc000459 With Placebo
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Oxagen Ltd · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
OC0000459 reduces inflammation in the tissues in response to allergic stimuli in patients with asthma. This clinical trial, in mildly asthmatic patients, studies the effects of OC000459 and placebo on the asthmatic response to two known stimulants of the asthmatic response in the lungs, namely cat hair, pollen or house dust mite and methacholine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OC000459 | Capsules twice daily for 15 days |
| DRUG | Placebo | Capsules twice daily for 15 days |
Timeline
- Start date
- 2006-02-01
- First posted
- 2010-01-26
- Last updated
- 2010-01-26
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01056692. Inclusion in this directory is not an endorsement.